NOWApril 1, 2026 at 5:36 PM UTCSoftware & Services

ServiceNow's Stock Drop Highlights AI Monetization Skepticism Despite Solid Backlog

Read source article

What happened

ServiceNow shares have plummeted over 30% year-to-date, as reported by Zacks, driven by fears of AI-native competition and slower growth, even as the company touts its expanding AI platform and $600 billion TAM. The DeepValue report reveals underlying strength, with FY25 cRPO growing 25% YoY to $12.85B and free cash flow reaching $4.636B, supporting a 'POTENTIAL BUY' rating. However, filings critically lack quantified AI monetization metrics, forcing investors to rely on management commentary for the core growth driver. Market sentiment has shifted, punishing the stock despite positive guidance, as skepticism mounts over whether AI agents can boost contract value without eroding subscription economics. This disconnect underscores the precarious balance between operational resilience and the unproven AI narrative.

Implication

The steep decline in ServiceNow's stock price signals that the market demands hard proof of AI monetization, making the Now Assist ACV trajectory toward $1B+ in 2026 a critical near-term catalyst. Downside risks include cRPO growth falling below subscription revenue, which would indicate weaker bookings quality and reduced forward visibility. Margin pressures from third-party cloud usage and acquisition amortization must remain contained to sustain the FCF margin narrative and support aggressive buybacks. Upcoming events, such as the Veza acquisition in 1H 2026 and potential AI-tier disclosures in filings, will be pivotal for re-rating the stock. Given the demanding P/E of 68.4, investors should approach with caution, using dips near the $105 attractive entry point for sizeable positions only if AI commercialization milestones are met.

Thesis delta

The thesis remains a 'POTENTIAL BUY' but with increased urgency; the YTD drop amplifies the need for AI monetization proof to offset market skepticism. If Now Assist ACV fails to progress toward $1B+ or cRPO growth decelerates materially, a downgrade is likely, though current levels near $115 offer a better entry for those betting on backlog durability.

Confidence

Medium